The Global Health Cost-Effectiveness Analysis (GH CEA) Registry is a database of cost-effectiveness analysis studies that evaluate a variety of health interventions worldwide. The Registry focuses on interventions designed to mitigate disease burden in countries at various stages of industrial development, using the disability-adjusted life year (DALY) as the primary measure of health. Developed with initial funding from the Bill and Melinda Gates Foundation, the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center created and maintains the current database.
The Global Health Cost Effectiveness Analysis (GH CEA) Registry is a free database that compiles research literature on the economic value of global health interventions. Our inclusion criterion for contributing articles is contingent on its application of the “cost-per-DALY-averted” metric, which measures the cost-effectiveness of an intervention.
The GH CEA Registry is a repository of all peer-reviewed cost-per-DALY studies stratified by methods, cost-per-DALY ratios, and disability weights published since the 1990s.
Global health organizations acknowledge the importance of prioritizing limited health care resources, but the question remains: are we spending our money wisely? Cost-effectiveness analysis can help stakeholders gain a better understanding of the return on investment of global health interventions and has the potential to inform smart investments and maximize the impact on population health.
- Global Burden of Disease Classification & ICD-10
- Primary, Secondary & Tertiary Prevention Classification
- Funding Source
- Study Perspective
- Target Population
- Intervention & Comparator
- Costs & DALYs
- Incremental Cost-Effectiveness Ratio (ICER)
- Disability Weight
GH CEA Registry Overview Brochure
Click here for a downloadable and printer-friendly pdf of the GH CEA Registry Overview Brochure. The brochure provides insight into our cost-per-DALY database, its contents and a succinct “getting started” section.